Navigation Links
Astute Medical, INC. ist Veranstalter eines SYMPOSIUMS zu Nierenerkrankungen beim 33. jährlichen ISICEM
Date:3/13/2013

SAN DIEGO, 14. März 2013 /PRNewswire/ -- Akutes Nierenversagen (AKI) tritt weltweit immer häufiger auf. Jedes Jahr sind Millionen von Patienten von dieser Erkrankung betroffen. Führende Experten für Intensivmedizin diskutieren bei einem Fortbildungssymposium neue Techniken zur Risikoeinschätzung von AKI . Die Veranstaltung findet am Mittwoch, 20. März 2013, um 12.30 Uhr im Rahmen des International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brüssel statt. Die Anmeldung erfolgt online auf AKIAssessment.com. Teilnehmer und andere Interessierte können die Veranstaltung live auf Twitter verfolgen: @ACuteKidneyMan.

Dr. John Kellum vom University of Pittsburgh Medical Center erläutert die Pathogenese von AKI sowie aktuelle Forschungsergebnisse [STUDIE ANZEIGEN]. Der Schwerpunkt liegt hierbei auf zwei Biomarkern, die eine sehr präzise Einschätzung des AKI-Risikos [VIDEO] ermöglichen und den derzeit üblichen Methoden überlegen sind. Dr. Lakhmir Chawla von der George Washington University und Dr. Andrew Shaw vom Duke University Medical Center referieren über Zellteilungsarrest-Biomarker in der AKI-Prophylaxe sowie Praxisimplikationen für das AKI-Management.

Immer mehr Krankenhausärzte in aller Welt weisen auf die hohen Gesundheitsrisiken und Kosten im Zusammenhang mit AKI hin.

„Nierenversagen ist eine Erkrankung mit hoher Mortalitätsrate und einer Auftretenshäufigkeit ähnlich der von Herzinfarkt – und deshalb auch genauso ernst zu nehmen", sagt Dr. Claudio Ronco , Leiter der Abteilung für Nephrologie im Krank
'/>"/>

SOURCE Astute Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Astute Medical, Inc. organizará el 33. simposio anual en el congreso ISICEM sobre daño renal
2. Astute Medical, Inc. ospiterà il simposio sullinsufficienza renale al 33o incontro annuale ISICEM
3. Astute Medical, Inc. promuove lultima generazione di biomarcatori per lesioni renali acute
4. Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury Biomarkers
5. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
6. Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Companys Commercialization Strategy
7. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
8. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Overall Category in Medical, Dental & Related Services/Trade
9. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management ... Product Strategy. In this role, Michelle will work with current ... in the development of iLab products. Her main goal will ... to the scientific community by offering the most advanced, user-friendly, ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... new way to manipulate light a million times more efficiently ... , Using a special hollow-core photonic crystal fibre, a ... door to what could prove to be a new sub-branch ... The team, led by Dr Fetah Benabid, reports on the ...
... PARK, Ill., Nov. 16 The Committee for,Medicinal ... of the,European Medicines Agency (EMEA), granted Abbott (NYSE: ... HUMIRA(R) (adalimumab) for the treatment,of moderate to severe ... for HUMIRA. Psoriasis is a non-contagious, chronic ...
... available in German . , Many scientists ... for the production of tiny particles with defined size ... in two or three dimensions and at both the ... applications in modern technology, from diagnostic systems to the ...
Cached Biology Technology:Discovery of a new way to manipulate light a million times more efficiently 2Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 2Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 3Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 4Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 5Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 6Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 7Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis 8Two-faced miniatures 2
(Date:4/22/2014)... secret to get your child to behave at the dinner ... Cornell study published in Eating Behaviors , found that ... bite with their front teeth such as drumsticks, whole apples, ... when these foods had been cut. "They were twice ... other kids," said Brian Wansink, Professor and Director of the ...
(Date:4/22/2014)... Scientists from the Florida campus of The Scripps ... plays a critical but previously unknown role in learning ... a novel role for a protein known as RGS7, ... eLife , a publisher supported by the Howard Hughes ... Trust. , "This is a critical building block that ...
(Date:4/22/2014)... of Massachusetts Amherst and the Instituto Nacional de Pesquisas ... have discovered a new genus and species of electric ... the Amazonia State of Brazil. , Professor Cristina Cox ... Antnio Alves-Gomes of INPA, describe the new bluntnose knifefish ... of the Natural Sciences of Philadelphia . , ...
Breaking Biology News(10 mins):Biting vs. chewing 2Scientists identify critical new protein complex involved in learning and memory 2New electric fish genus and species discovered in Brazil's Rio Negro 2
... A major initiative to create alternative nesting sites for the ... help protect juvenile salmon and steelhead in the Columbia River ... nesting site at Crump Lake in southern Oregon, which was just ... more than 135 nesting pairs of Caspian terns, as well as ...
... called for Europe to invest more funds into the study ... role in the function of human cells and which are ... to Alzheimer,s. Common lipids such as cholesterol are known ... cells and tissues, but human cells contain thousands of different ...
... Belfast is appealing for help from the public in looking ... Activities such as aquaculture, shipping and recreational boating have led ... Now Queen,s is attempting to find out exactly where and how ... this it is asking for help from the public to record ...
Cached Biology News:Project succeeding to relocate Caspian terns 2Project succeeding to relocate Caspian terns 3Project succeeding to relocate Caspian terns 4Project succeeding to relocate Caspian terns 5Project succeeding to relocate Caspian terns 6Europe-wide investment in lipid research will help tackle disease, says new report 2Queen's marine biologist investigates aliens beneath the waves 2
... Stabilizer is an aqueous solution that contains ... chemicals in a PBS buffer (phosphate buffered ... product does not contain a preservative. ... activity of dried protein components in immunoassays ...
Mouse polyclonal antibody to BTG2 - BTG family, member 2...
These 96-well 0.2 ml thin-wall PCR plate caps are caps that are used to seal 96-well, 0.2 ml thin-wall PCR plates. Supplied as 300 caps....
... for assays of mouse hematopoietic progenitors from ... Suitable for the growth of mouse ... to methylcellulose at a final concentration of ... also support growth of mouse IL-3 dependent ...
Biology Products: